We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Consensus and Guidelines · January 06, 2020

Role and Safety of New Glucose-Lowering Drugs in Patients With Heart Failure

European Journal of Heart Failure

 

Additional Info

European Journal of Heart Failure
European Society of Cardiology/Heart Failure Association Position Paper on the Role and Safety of New Glucose-Lowering Drugs in Patients With Heart Failure
Eur. J. Heart Fail 2019 Dec 09;[EPub Ahead of Print], PM Seferović, AJS Coats, P Ponikowski, G Filippatos, M Huelsmann, PS Jhund, MM Polovina, M Komajda, J Seferović, I Sari, F Cosentino, G Ambrosio, M Metra, M Piepoli, O Chioncel, LH Lund, T Thum, RA De Boer, W Mullens, Y Lopatin, M Volterrani, L Hill, J Bauersachs, A Lyon, MC Petrie, S Anker, GMC Rosano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading